Precision Business Insights has published a report on the global RNA based therapeutics and vaccines market, estimating its value at USD 63,626 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 3.8% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/rna-based-therapeutics-and-vaccines-market
RNA-based therapies and vaccines use a variety of RNA modalities, including messenger RNA (mRNA), RNA interference (RNAi), and antisense oligonucleotides (ASOs), to modify gene expression or trigger immunological responses. These technologies enable the focused treatment of genetic illnesses, malignancies, and infectious ailments, with benefits such as fast development, high specificity, and reduced manufacturing complexity.
Drivers:
- Global health preparedness: RNA platforms offer rapid response capabilities for emerging infectious diseases and pandemic threats.
- Technological advancements: Innovations in delivery systems (e.g., lipid nanoparticles) and RNA stabilization have improved efficacy and shelf life
The global RNA based therapeutics and vaccines market segmentation:
1) By Product: RNA-based Therapeutics, RNA-based Vaccines
2) By Indication: Oncology, Ophthalmic Disorders, Immunology, Cardiovascular Disorders, Infectious Diseases, Genetic Disorders, CNS Disorders, Others
3) By Type: siRNA, ASO, mRNA, saRNA, miRNA, tRNA, Aptamers, Others
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=38090
Regional Overview:
The report also examines the current concerns and their Future Effects on the RNA based therapeutics and vaccines market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the RNA based therapeutics and vaccines market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Moderna Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corp, Sylentis S.A., Santaris Pharma A/S, Arrowhead Pharmaceuticals, Inc., BioNTech AG, Regulus Therapeutics, Inc., CureVac AG, Dicerna Pharmaceuticals AG, Marina Biotech, Inc., miRagen Therapeutics, Quark Pharmaceuticals, Inc., Pfizer Inc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
